|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by/(used in) operations: | |||||
| Depreciation and amortization | |||||
| Employee stock awards | |||||
| Stock grants | |||||
| Contingent consideration payable fair value | |||||
| Gain on disposal of assets | |||||
| Common stock purchase options | |||||
| Debt discount amortization | |||||
| Amortization of contract costs | |||||
| Stock-based compensation | |||||
| Loss on disposal of assets | |||||
| Allowance for credit losses | |||||
| Gain on sale of equity investment | |||||
| Gain on extinguishment of debt | |||||
| Impairment of right of use asset | |||||
| Reduction in right of use asset | |||||
| Valuation allowance | |||||
| Deferred income taxes | |||||
| Changes in current assets and liabilities | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other noncurrent assets | |||||
| Deposits | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Income tax payable | |||||
| Other noncurrent liabilities | |||||
| Operating lease liability | |||||
| Net cash provided by operating activities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flow from investing activities: | |||||
| Sale of the ammunition business assets | |||||
| Proceeds from the sale of equity investments | |||||
| Purchase of property and equipment | |||||
| Proceeds from disposal of assets | |||||
| Net cash used in investing activities | |||||
| Net cash provided by/(used in) investing activities | |||||
| Cash flow from financing activities: | |||||
| Proceeds from factoring liability | |||||
| Payments on factoring liability | |||||
| Payments on note payable - related party | |||||
| Payments on construction note payable | |||||
| Payments on insurance premium note payment | |||||
| Common stock issued for exercised warrants | |||||
| Repurchase of common shares | |||||
| Preferred stock dividends paid | |||||
| Common stock repurchase plan | |||||
| Net cash used in financing activities | |||||
| Cash flow from discontinued operations: | |||||
| Net provided by/(cash used in) operating activities of discontinued operations | |||||
| Net cash provided by/(used in) investing activities of discontinued operations | |||||
| Net cash used in financing activities of discontinued operations | |||||
| Net cash provided by (used in) discontinued operations | |||||
| Net increase/(decrease) in cash | |||||
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance | |||||
| Cash, beginning of period | |||||
| Restricted cash, beginning of period | |||||
| Cash and restricted cash, end of period | |||||
| Cash, end of period | |||||
| Supplemental cash flow disclosures: | |||||
| Interest | |||||
| Income taxes | |||||
| Non-cash investing and financing activities: | |||||
| Operating lease liability | |||||
| Issuance of notes payable - related party in DE Litigation settlement, net of discount | |||||
| Warrant issued for legal settlement - related party in DE Litigation settlement | |||||
| Warrant issued to extinguish debt | |||||
| Note issued for insurance premium payment | |||||
| Dividends accumulated on preferred stock | |||||
| Operating lease assets obtained in exchange for new lease liabilities | |||||
Loading...